Bio-Rad Laboratories | BIO - Net Income

Stock Price
247.53
Daily Change
1.26 0.51%
Monthly
-14.96%
Yearly
-0.37%
Q2 Forecast
242.55

Bio-Rad Laboratories reported $720M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Agilent USD 305M 129M Dec/2025
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Bio Techne USD 51.05M 13.04M Mar/2026
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
Bruker USD 3.5M 22.5M Mar/2026
Charles River Laboratories USD -14.84M 261.71M Mar/2026
Danaher USD 1.03B 168M Mar/2026
General Electric Aerospace USD 1.9B 637M Mar/2026
Illumina USD 134M 200M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Laboratory Of America USD 277.8M 113.1M Mar/2026
Merck USD -4.24B 7.2B Mar/2026
Mettler Toledo International USD 169.45M 116.31M Mar/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 251M 6M Mar/2026
Repligen USD 8.33M 4.95M Mar/2026
Revvity USD 40.72M 57.65M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Siemens EUR 2.03B 3M Mar/2026
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Tosoh JPY 16.99B 266M Mar/2026
Waters USD -72M 297.21M Mar/2026